These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31435771)

  • 21. The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease.
    Qiu WY; Yang Q; Zhang W; Wang N; Zhang D; Huang Y; Ma C
    Curr Alzheimer Res; 2018 Mar; 15(5):462-473. PubMed ID: 29110614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults.
    Papaliagkas V; Papantoniou G; Tsolaki M; Moraitou D
    Hell J Nucl Med; 2017; 20 Suppl():58-70. PubMed ID: 29324915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations Between Personality Traits and Cognitive Resilience in Older Adults.
    Graham EK; James BD; Jackson KL; Willroth EC; Boyle P; Wilson R; Bennett DA; Mroczek DK
    J Gerontol B Psychol Sci Soc Sci; 2021 Jan; 76(1):6-19. PubMed ID: 32969474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults.
    Armstrong NM; An Y; Beason-Held L; Doshi J; Erus G; Ferrucci L; Davatzikos C; Resnick SM
    Neurobiol Aging; 2019 Mar; 75():178-186. PubMed ID: 30580127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in Alzheimer's disease and common neuropathologies of aging.
    Oveisgharan S; Arvanitakis Z; Yu L; Farfel J; Schneider JA; Bennett DA
    Acta Neuropathol; 2018 Dec; 136(6):887-900. PubMed ID: 30334074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.
    Nag S; Yu L; Capuano AW; Wilson RS; Leurgans SE; Bennett DA; Schneider JA
    Ann Neurol; 2015 Jun; 77(6):942-52. PubMed ID: 25707479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline.
    Hohman TJ; Tommet D; Marks S; Contreras J; Jones R; Mungas D;
    Neurobiol Aging; 2017 Oct; 58():120-128. PubMed ID: 28732249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.
    Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB
    Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in the association between AD biomarkers and cognitive decline.
    Koran MEI; Wagener M; Hohman TJ;
    Brain Imaging Behav; 2017 Feb; 11(1):205-213. PubMed ID: 26843008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire.
    Malek-Ahmadi M; Chen K; Davis K; Belden CM; Powell J; Jacobson SA; Sabbagh MN
    Alzheimers Res Ther; 2015 Jan; 7():1. PubMed ID: 26584966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.